MultiplexDX Inc.

company

About

Developing products for precision medicine: affordable, reliable, specific, quantifiable, and accurate precision diagnostic technology.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€1.20M
Industries
Biotechnology,Health Diagnostics,Pharmaceutical
Founded date
Nov 30, 2015
Number Of Employee
1 - 10
Operating Status
Active

MultiplexDX is a biotech diagnostics company, developing accurate, specific, quantifiable, and affordable diagnostic tests. It aims to provide effective and successful treatment of tumors and prevent cancer. To achieve this, the company is in the phase of developing a new visualization technology combining the approach of molecular biology and histopathological methods. This technology has an ambition to surpass the limitations of existing medical diagnostic and prognostic methods and to take a key role in this fast-changing market.

MultiplexDX operates from Kosice, Slovakia and Maryland, US and is currently serving first clients on both European and US markets.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
€1.20M
MultiplexDX Inc. has raised a total of €1.20M in funding over 2 rounds. Their latest funding was raised on Oct 4, 2018 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 4, 2018 Series Unknown €1.20M 1 Detail
Oct 28, 2016 Series Unknown 1 Detail
Feb 1, 2016 Seed 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
MultiplexDX Inc. is funded by 1 investors. Neulogy Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Neulogy Ventures Series Unknown